+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Avanir Pharmaceuticals Inc - logo

Avanir Pharmaceuticals focuses on the research, development and commercialization of novel medical and pharmaceutical treatments for people with central nervous system disorders. It primarily offers NUEDEXTA, a dual N-methyl-D-aspartate receptor antagonist and sigma-1 agonist for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores. Avanir Pharmaceuticals was founded in 1988 and is headquartered in Aliso Viejo, California.

Alzheimer's Disease: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Alzheimer's Disease: Global Drug Forecast and Market Analysis to 2028

  • Report
  • May 2020
  • 218 Pages
  • Global
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 Pages
  • Global
From
Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030 - Product Thumbnail Image

Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030

  • Report
  • October 2019
  • 231 Pages
  • Global
From
Alzheimer's Disease: Competitive Landscape to 2026 - Product Thumbnail Image

Alzheimer's Disease: Competitive Landscape to 2026

  • Report
  • June 2018
  • 49 Pages
  • Global
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
Dementia - Pipeline Review, H2 2020 - Product Thumbnail Image

Dementia - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 537 Pages
  • Global
From
Traumatic Brain Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Traumatic Brain Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 440 Pages
  • Global
From
Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2029 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) - Opportunity Analysis and Forecasts to 2029

  • Report
  • September 2020
  • 128 Pages
  • Global
From
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025 - Product Thumbnail Image

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • Report
  • August 2018
  • 340 Pages
  • Global
From
Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Noradrenaline Transporter (NAT or Norepinephrine Transporter or NET) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Avanir Pharmaceuticals Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Avanir Pharmaceuticals Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Avanir Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2022
  • 25 Pages
From
Loading Indicator